MiRXES is a biotechnology company focused on early, actionable, and personalized diagnoses. We specialize in genomic sequencing services, microRNA technologies, and the development, manufacturing, and provision of diagnostic test kits and clinical testing services. Our mission is to enable early disease detection and provide insights for better patient care by harnessing the power of microRNA and omics to augment traditional testing. Our vision is to be the world’s leading developer and provider of accurate, actionable, and affordable microRNA-powered diagnostic tests and services.
Company Details
- Founded
- 2014
- Address
- 2 Tukang Innovation Grove, Jtc Medtech Hub, #09-02, Singapore,618305,singapore
- Industry
- Biotechnology
- Website
- https://mirxes.us
- Keywords
- microRNA, miRNA, Biopharma, R&D Collaboration, R&D partnership, CRO, Commercialization, Diagnostics, microRNA detection, qPCR, Life Science Research, RNA, Discovery, Development, Manufacturing, IVD, Biomarker, RT-qPCR, ncRNA.
- HQ
- Singapore
Mirxes Usa Questions
Mirxes Usa's website is https://mirxes.us
Mirxes Usa's LinkedIn profile is https://sg.linkedin.com/company/mirxes-usa
Mirxes Usa's industry is
Biotechnology
Mirxes Usa's top competitors are
Active Intelligence,
Illumina,
Allozymes,
Empathly,
Mirxes Hong Kong,
Cellvec Pte Ltd,
Mirxes,
Lucence,
Hummingbird Bioscience,
Tessa Therapeutics Ltd.
Mirxes Usa's categories are Biotechnology
Mirxes Usa's founding year is 2014
